TimepointDx is engaged patient-centric blood sampling via novel capillary blood collection technologies for downstream translational discovery, exploratory biomarkers and diagnostics operations in pharmaceutical clinical trials and research. As pioneers of Longitudinal Capillary Multiomics™ (LCM™), TimepointDx enables robust longitudinal multiomics (genomics, transcriptomics, and proteomics) as standard of practice for clinical trials. LCM™ enables standardized and harmonized longitudinal capillary multiomics to create rich biomarker stories of clinical trial participants. TimepointDx is also pioneering novel technologies, including Aggregated Longitudinal Sequencing™ (ALseq™) for cost-effective WGS + WES and Capillary Stem Cell Reprogramming™ (CSCR™) for patient-specific iPSCs in vitro disease modeling. Learn more at www.timepointdx.com

TimepointDx

Org chart

Teams

Offices